Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance)

BACKGROUND. Preclinical and epidemiological data suggest that metformin might have antineoplastic properties against colon cancer (CC). However, the effect of metformin use on patient survival in stage III CC after curative resection is unknown. The survival outcomes were comparable regardless of th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncologist
Päätekijät: Singh, Preet Paul, Shi, Qian, Foster, Nathan R., Grothey, Axel, Nair, Suresh G., Chan, Emily, Shields, Anthony F., Goldberg, Richard M., Gill, Sharlene, Kahlenberg, Morton S., Sinicrope, Frank A., Sargent, Daniel J., Alberts, Steven R.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AlphaMed Press 2016
Aiheet:
Gastrointestinal Cancer
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5153338/
https://ncbi.nlm.nih.gov/pubmed/27881709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0153
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia